Is a drug holiday from Vyvanse (lisdexamfetamine) safe, and what are the recommended guidelines for implementing it in pediatric and adult patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug Holidays from Vyvanse (Lisdexamfetamine)

Drug holidays from Vyvanse are a safe and commonly practiced strategy that can serve multiple clinical purposes, including assessment of ongoing medication need, management of side effects (particularly appetite suppression and insomnia), and enabling catch-up growth in pediatric patients. 1

Evidence Supporting Drug Holiday Practice

Prevalence and Patterns

  • Drug holidays are practiced by 25–70% of families taking ADHD stimulant medications, with most families implementing them during school holidays rather than weekends. 1
  • Shorter breaks (weekends) can reduce insomnia and improve appetite, while longer breaks (school holidays) show positive impact on child growth when medication has suppressed growth parameters. 1

Clinical Purposes of Drug Holidays

  • Assessment function – Drug holidays allow testing whether medication is still needed, particularly valuable for adolescents showing signs of wanting to discontinue treatment prematurely, as they can self-assess their ability to manage without medication under medical supervision. 2
  • Side effect management – Planned breaks address common adverse effects including appetite suppression (incidence ≥5%), insomnia (incidence ≥5%), and growth suppression, which are among the most frequent dose-limiting side effects of lisdexamfetamine. 3, 1
  • Drug tolerance assessment – Families use drug holidays to evaluate whether tolerance has developed, though evidence shows little development of tolerance to stimulant effects on ADHD symptoms with appropriate dosing. 1

Safety Profile During Drug Holidays

No Withdrawal Syndrome

  • Lisdexamfetamine can be discontinued immediately without a washout period because stimulants do not produce physiologic dependence requiring tapering in therapeutic use. 4
  • The prodrug design of lisdexamfetamine, which requires enzymatic hydrolysis in blood to convert to active d-amphetamine, provides a gradual offset of effect that may reduce rebound symptoms compared to immediate-release formulations. 5, 6

Monitoring During Holidays

  • Families should monitor for return of core ADHD symptoms including inattention, hyperactivity, and impulsivity during the drug holiday period. 1
  • Parents' ability to cope with the child's behavior and the child's academic progress are key factors influencing the decision to continue or resume medication after a holiday. 2

Implementation Guidelines

Timing Recommendations

  • School holidays are the preferred time for longer drug holidays (1–2 weeks or more) because they minimize academic impact and allow assessment in a lower-demand environment. 1, 2
  • Weekend holidays can be implemented for brief assessment periods or to provide relief from appetite suppression and insomnia, though they offer less opportunity for comprehensive evaluation. 1

Pediatric Considerations

  • In children experiencing growth suppression (a documented long-term effect of stimulants), planned drug holidays during school breaks can enable catch-up growth while maintaining treatment during the academic year when functional impairment is greatest. 3, 1
  • Height and weight should be monitored at each visit during maintenance treatment, and drug holidays should be considered when growth velocity declines below expected parameters. 4

Adult Considerations

  • Adults may implement drug holidays on weekends or during vacation periods to assess ongoing need for medication, particularly if they question whether ADHD symptoms have improved with maturity. 1
  • The decision should balance functional impairment in work and social settings against the desire to minimize medication exposure. 2

Barriers to Practitioner-Initiated Drug Holidays

Current Practice Gaps

  • Drug holidays are typically reactively initiated by families rather than proactively recommended by practitioners as part of routine care, despite guideline recommendations for annual assessment of continuing medication need. 7
  • Practitioners report lack of time, absence of educational materials about drug holidays, and uncertainty about the need for planned breaks as key barriers to discussing this option. 7

Addressing Barriers

  • Child and Adolescent Mental Health Service (CAMHS) practitioners often question the need for drug holidays, while general practitioners are more accepting due to concerns about long-term side effects and cost considerations. 7
  • Educational interventions and decision aids could help families make informed decisions about implementing drug holidays. 7

Clinical Algorithm for Drug Holiday Implementation

  1. Annual review – At least yearly, discuss with patients and families whether a trial period off medication would be appropriate to assess ongoing need. 7

  2. Identify optimal timing – Schedule drug holidays during school breaks (summer, winter, spring) for pediatric patients, or during vacation periods for adults, to minimize functional impact. 1, 2

  3. Set duration – Plan for 1–2 weeks minimum to allow adequate assessment of symptom return and side effect resolution; longer periods (4–6 weeks) may be needed to observe catch-up growth in children. 1

  4. Monitor systematically – Use standardized ADHD rating scales from parents, teachers (if applicable), and patients to objectively measure symptom change during the holiday period. 4

  5. Assess outcomes – Evaluate whether ADHD symptoms return to impairing levels, whether side effects resolve (appetite, sleep, growth), and whether the patient and family feel medication is still needed. 1, 2

  6. Resume or adjust – If symptoms return and cause significant impairment, resume medication at the previous effective dose; if symptoms remain manageable, consider extending the holiday or discontinuing treatment with close follow-up. 2

Common Pitfalls to Avoid

  • Do not implement drug holidays during critical academic periods (exams, major projects) or high-demand work periods, as this sets up the patient for failure and may lead to premature conclusions about medication need. 2
  • Do not assume drug holidays are only for managing side effects – they serve multiple purposes including assessment, prevention of premature discontinuation, and negotiation of treatment plans with adolescents. 1
  • Do not fail to provide structure and support during holidays – families need guidance on what to monitor and how to assess whether the break is successful. 7
  • Do not continue medication indefinitely without periodic reassessment – guidelines call for annual evaluation of continuing need, which drug holidays can facilitate. 7

Related Questions

Is a drug holiday from Attention Deficit Hyperactivity Disorder (ADHD) medication, such as methylphenidate (Ritalin) or amphetamine, recommended for this patient?
Can a female of childbearing age with Attention Deficit Hyperactivity Disorder (ADHD) take Vyvanse (lisdexamfetamine) with Yasmin (drospirenone and ethinyl estradiol) and Lion's Mane (Hericium erinaceus) together?
How can I safely transition a patient on Adderall (dextroamphetamine‑amphetamine) 5 mg once daily to Vyvanse (lisdexamfetamine), including appropriate initial dose, titration schedule, and necessary cardiovascular and psychiatric monitoring?
Are there any drug interactions or safety concerns for a patient taking propranolol 40 mg daily together with lisdexamfetamine (Vyvanse) 70 mg daily, dexamfetamine 5 mg six times daily, olanzapine 2.5 mg nightly, and fluorometholone 0.1% eye drops?
Can I prescribe Vyvanse (lisdexamfetamine) 20 mg in the afternoon at the patient’s request?
How should a urinary tract infection caused by Pseudomonas aeruginosa in a female patient be interpreted and managed?
What long‑term antiplatelet therapy is recommended for a patient five years after percutaneous coronary intervention who has a moderate risk of gastrointestinal bleeding?
Can Entresto (sacubitril/valsartan) be used in a patient with end‑stage renal disease on hemodialysis who has heart failure with reduced ejection fraction, and how should it be initiated and monitored?
Can metoprolol be taken with or without food, and does it differ for immediate‑release versus extended‑release formulations?
What is the appropriate evaluation and initial management for a 44-year-old woman presenting with an itchy rash localized to the face and neck?
What is the appropriate treatment for knee pain in a 62-year-old woman?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.